This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Durmaz, R.
Right arrow Articles by Rastogi, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Durmaz, R.
Right arrow Articles by Rastogi, N.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 2007, p. 4027-4035, Vol. 45, No. 12
0095-1137/07/$08.00+0     doi:10.1128/JCM.01308-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Population-Based Molecular Epidemiological Study of Tuberculosis in Malatya, Turkey{triangledown}

Riza Durmaz,1* Thierry Zozio,2 Selami Gunal,1 Caroline Allix,3 Maryse Fauville-Dufaux,3 and Nalin Rastogi2*

Department of Clinical Microbiology, Faculty of Medicine, Inonu University, Malatya, Turkey,1 Unité de la Tuberculose et des Mycobactéries, Institut Pasteur de Guadeloupe, Pointe-à-Pitre, Guadeloupe,2 Laboratoire Tuberculose et Mycobacteries, Institut Pasteur de Bruxelles, Bruxelles, Belgium3

Received 29 June 2007/ Returned for modification 7 August 2007/ Accepted 27 September 2007

This investigation describes drug resistance patterns and genotyping data on a total of 145 Mycobacterium tuberculosis strains isolated between 2000 and 2004 in Malatya, Turkey. Drug susceptibility results indicated a total of 20% resistant and 4.8% of multidrug-resistant isolates. Spoligotyping resulted in 25 unique patterns and 120 strains in 19 clusters (2 to 33 strains per cluster). When the results were compared to an international spoligotyping database, 19 of 25 unique patterns matched existing shared spoligotype international types (SITs). This led to the description of 38 SITs with 139 strains and 6 orphan patterns (not previously reported). Five of the SITs (SIT759, SIT1936, SIT1937, SIT1938, and SIT2285) were newly created. The most prevalent spoligotype was SIT41 (LAM7-TUR) with 33 (23.9%) isolates. The repartition of strains according to major M. tuberculosis clades (in decreasing order) was as follows: ill-defined T clade (45.7%) > Latin American and Mediterranean (LAM; 29%) > Haarlem (15.9%). Strains belonging to Central Asian (CAS), East-African Indian (EAI), Beijing, and Africanum clades were absent in this setting. IS6110-restriction fragment length polymorphism (RFLP) resulted in 19 clusters (52 strains), with a final clustering rate of 35.9% and a recent transmission rate of 22.8%. Typing based on mycobacterial interspersed repetitive units (MIRUs) permitted us to identify 65 patterns (23 orphan patterns and 42 patterns that matched existing MIRU international types in an updated database). The combination of the three typing methods allowed us to calculate a final clustering rate of 22% and a significantly lower transmission rate of 13.1%. The discrimination achieved by IS6110-RFLP/MIRUs was not significantly improved by adding spoligotyping results (1.4%). We conclude that our patient population is infected by diverse M. tuberculosis populations; however, the majority of the ongoing transmission is due to "evolutionary recent" tuberculosis lineages belonging to principal genetic group 2 (PGG2; Haarlem and LAM) and PGG3 (ill-defined T clade), and most of it is attributable to the LAM7-TUR sublineage with an enhanced phylogeographical specificity for Turkey. An absence of lineages belonging to PGG1 clones (EAI, CAS, and Beijing, essentially found in Central, South, and Southeast Asia), is noteworthy.

* Corresponding author. Mailing address for R. Durmaz: Department of Clinical Microbiology, Molecular Microbiology Section, Faculty of Medicine, Inonu University, 44069 Malatya, Turkey. Phone: 90-422-3410126. Fax: 90-422-3410728. E-mail: rdurmaz{at}inonu.edu.tr. Mailing address for N. Rastogi: Unité de la Tuberculose et des Mycobactéries, Institut Pasteur de Guadeloupe, BP484, 97183 Abymes, Guadeloupe. Phone: 590-590-897661. Fax: 590-590-893880. E-mail: nrastogi{at}pasteur-guadeloupe.fr

{triangledown} Published ahead of print on 10 October 2007.

Journal of Clinical Microbiology, December 2007, p. 4027-4035, Vol. 45, No. 12
0095-1137/07/$08.00+0     doi:10.1128/JCM.01308-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»